![Ryan Asay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Ryan Asay worked as a Director of Investor Relations at Bristol Myers Squibb Co. He then worked as the Head of Investor Relations at Spark Therapeutics, Inc. from 2017 to 2020.
From 2020 to 2024, he worked as the Vice President and Head of Corporate Affairs at Mirati Therapeutics, Inc.
Precedenti posizioni note di Ryan Asay
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 23/01/2024 |
| SPARK THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/02/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
21
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
